UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enhanced secretion of glucagon-like peptide 1 by biguanide compounds

Biochemical and biophysical research communications, 2002-11, Vol.298 (5), p.779-784

2002

Volltextzugriff (PDF)

Metformin causes reduction of food intake and body weight gain and improvement of glucose intolerance in combination with dipeptidyl peptidase IV inhibitor in Zucker fa/fa rats

The Journal of pharmacology and experimental therapeutics, 2004-08, Vol.310 (2), p.614-619

2004

Volltextzugriff (PDF)

Comparison of Efficacies of a Dipeptidyl Peptidase IV Inhibitor and α-Glucosidase Inhibitors in Oral Carbohydrate and Meal Tolerance Tests and the Effects of Their Combination in Mice

Journal of Pharmacological Sciences, 2007, Vol.104(1), pp.29-38

2007

Volltextzugriff (PDF)

7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one is a novel competitive and selective inhibitor of dipeptidyl peptidase IV with an antihyperglycemic activity

The Journal of pharmacology and experimental therapeutics, 2006-12, Vol.319 (3), p.1253-1257

2006

Volltextzugriff (PDF)

Effects of the combination of a dipeptidyl peptidase IV inhibitor and an insulin secretagogue on glucose and insulin levels in mice and rats

The Journal of pharmacology and experimental therapeutics, 2007-02, Vol.320 (2), p.738-746

2007

Volltextzugriff (PDF)

Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes

Journal of lipid research, 2003-01, Vol.44 (1), p.128-135

2003

Volltextzugriff (PDF)

The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight

European journal of pharmacology, 2004-03, Vol.488 (1), p.213-218

2004

Volltextzugriff (PDF)

Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-coa reductase inhibitors

Journal of lipid research, 2000-07, Vol.41 (7), p.1136-1144

2000

Volltextzugriff (PDF)

Risks of the Spontaneous Ignition of the Rubble which Caused by the Heat Generation of Fermentation

Bulletin of Japan Association for Fire Science and Engineering, 2012, Vol.62(2_3), pp.49-57

2012

Volltextzugriff (PDF)

Trimethylsilyl Bis(trifluoromethanesulfonyl)amide as an Effective Catalyst for the Friedel-Crafts Alkylation Reaction

Synlett, 1997-10, Vol.1997 (10), p.1145-1146

1997

Volltextzugriff (PDF)

Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism

European journal of pharmacology, 2001-11, Vol.431 (3), p.345-352

2001

Volltextzugriff (PDF)

Cyclic GMP Phosphodiesterase Inhibitors. 2. Requirement of 6-Substitution of Quinazoline Derivatives for Potent and Selective Inhibitory Activity

Journal of medicinal chemistry, 1994-06, Vol.37 (13), p.2106-2111

1994

Volltextzugriff (PDF)

E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo [4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor

European journal of pharmacology, 2006-10, Vol.548 (1-3), p.181-187

2006

Volltextzugriff (PDF)

Making Accurate and Consistent Wafer Measurements with Next Generation Guarded True-Kelvin MEMS DC Probes

2024 IEEE 36th International Conference on Microelectronic Test Structures (ICMTS), 2024, p.1-5

2024

Volltextzugriff (PDF)

Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits

Atherosclerosis, 1994-06, Vol.107 (2), p.187-201

1994

Volltextzugriff (PDF)

Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits

Atherosclerosis, 1996-08, Vol.124 (2), p.203-210

1996

Volltextzugriff (PDF)

E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor

European journal of pharmacology, 2006-10, Vol.548 (1-3), p.181

2006

Volltextzugriff (PDF)

Cyclic GMP phosphodiesterase inhibitors. 1. The discovery of a novel potent inhibitor, 4-[[3,4-(methylenedioxy)benzyl]amino]-6,7,8-trimethoxyquinazoline

Journal of medicinal chemistry, 1993-11, Vol.36 (24), p.3765-3770

1993

Volltextzugriff (PDF)

Mechanisms of Satigrel (E5510), a New Anti-platelet Drug, in Inhibiting Human Platelet Aggregation. Selectivity and Potency against Prostaglandin H Synthases Isozyme Activities and Phosphodiesterase Isoform Activities

Biological and Pharmaceutical Bulletin, 1996/06/15, Vol.19(6), pp.828-833

1996

Volltextzugriff (PDF)

Lanthanide Perfluoroalkylsulfonylamide Catalysts for Fluorous Phase Organic Synthesis

Synlett, 1998-12, Vol.1998 (12), p.1347-1348

1998

Volltextzugriff (PDF)

Comparison of Efficacies of a Dipeptidyl Peptidase IV Inhibitor and α-Glucosidase Inhibitors in Oral Carbohydrate and Meal Tolerance Tests and the Effects of Their Combination in Mice

Journal of Pharmacological Sciences, 2007, Vol.104 (1), p.29-38

2007

Volltextzugriff (PDF)

E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4 H-imidazo[4,5- d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor

European journal of pharmacology, 2006, Vol.548 (1), p.181-187

2006

Volltextzugriff (PDF)

Section Review Cardiovascular & Renal: Phosphodiesterase 5 inhibitors in development for cardiovascular therapy

Expert opinion on investigational drugs, 1996-11, Vol.5 (11), p.1477-1486

1996

Volltextzugriff (PDF)

発酵による発熱を原因とした瓦礫類の火災危険性について

日本火災学会論文集, 2012, Vol.62(2_3), pp.49-57

2012

Volltextzugriff (PDF)

Microsomal Reductase for Aromatic Aldehydes and Ketones in Guinea Pig Liver. Purification, Characterization, and Functional Relationship to Hexose-6-Phosphate Dehydrogenase

Journal of biochemistry (Tokyo), 1981-10, Vol.90 (4), p.1077-1085

1981

Volltextzugriff (PDF)

1 – 25 von 336

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(286)

Publikationsform

Sprache

Englisch
(274)
Japanisch
(86)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Enhanced secretion of glucagon-like peptide 1 by biguanide compounds

Metformin causes reduction of food intake and body weight gain and improvement of glucose intolerance in combination with dipeptidyl peptidase IV inhibitor in Zucker fa/fa rats

Comparison of Efficacies of a Dipeptidyl Peptidase IV Inhibitor and α-Glucosidase Inhibitors in Oral Carbohydrate and Meal Tolerance Tests and the Effects of Their Combination in Mice

7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one is a novel competitive and selective inhibitor of dipeptidyl peptidase IV with an antihyperglycemic activity

Effects of the combination of a dipeptidyl peptidase IV inhibitor and an insulin secretagogue on glucose and insulin levels in mice and rats

Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes

The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight

Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-coa reductase inhibitors

Risks of the Spontaneous Ignition of the Rubble which Caused by the Heat Generation of Fermentation

Trimethylsilyl Bis(trifluoromethanesulfonyl)amide as an Effective Catalyst for the Friedel-Crafts Alkylation Reaction

Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism

Cyclic GMP Phosphodiesterase Inhibitors. 2. Requirement of 6-Substitution of Quinazoline Derivatives for Potent and Selective Inhibitory Activity

E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo [4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor

Making Accurate and Consistent Wafer Measurements with Next Generation Guarded True-Kelvin MEMS DC Probes

Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits

Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits

E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor

Cyclic GMP phosphodiesterase inhibitors. 1. The discovery of a novel potent inhibitor, 4-[[3,4-(methylenedioxy)benzyl]amino]-6,7,8-trimethoxyquinazoline

Mechanisms of Satigrel (E5510), a New Anti-platelet Drug, in Inhibiting Human Platelet Aggregation. Selectivity and Potency against Prostaglandin H Synthases Isozyme Activities and Phosphodiesterase Isoform Activities

Lanthanide Perfluoroalkylsulfonylamide Catalysts for Fluorous Phase Organic Synthesis

Comparison of Efficacies of a Dipeptidyl Peptidase IV Inhibitor and α-Glucosidase Inhibitors in Oral Carbohydrate and Meal Tolerance Tests and the Effects of Their Combination in Mice

E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4 H-imidazo[4,5- d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor

Section Review Cardiovascular & Renal: Phosphodiesterase 5 inhibitors in development for cardiovascular therapy

発酵による発熱を原因とした瓦礫類の火災危険性について

Microsomal Reductase for Aromatic Aldehydes and Ketones in Guinea Pig Liver. Purification, Characterization, and Functional Relationship to Hexose-6-Phosphate Dehydrogenase

Suchergebnisse filtern